EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (5 weeks ago)
Read our latest #SaferWorldbydesign newsletter highlighting SaferSkin™ new features and products. #SaferSkin… https://t.co/z9SmrlJ3Yb
Edelweiss Connect (5 weeks ago)
Curation of drug-induced mechanistic toxicological processes and adverse outcome pathway in (DILI) Presented by Cu… https://t.co/8n0QoR3gXa
Edelweiss Connect (5 weeks ago)
The approach may be further extended by additional in silico and in vitro methods to strengthen the weight of evide… https://t.co/oLCdYGMTnW
Edelweiss Connect (5 weeks ago)
Our #SaferSkin™ app implements three well-adopted approaches to perform an integrated analysis of the OECD-approved… https://t.co/MA7DY0RdwO
Edelweiss Connect (6 weeks ago)
#SaferWorldbyDesign & @MultiCASEInc present: Use of in silico methods for assessing toxicity #QSAR #insilico… https://t.co/AgoolrhT7M

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA